Acutus Medical Inc expected to post a loss of 71 cents a share - Earnings Preview

Acutus Medical

14/03/2023 21:08

* Acutus Medical Inc  AFIB.OQ   AFIB.O  is expected to show
a fall
in quarterly revenue when it reports  results on March 16. 
    * The Carlsbad California-based  company is expected to
report  a
1.1% decrease in revenue to $4.316 million from $4.36 million a
year ago, according to the mean estimate from 4 analysts, based
on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Acutus Medical Inc
is for
a loss of 71 cents per share. 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 2
"hold" and 1 "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Acutus
Medical
Inc is $2.21​, above​ its last closing price of $0.89. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2022  -0.82       -0.81      -0.72     Beat    10.9
 Jun. 30 2022  -0.82       -0.80      -1.38     Missed  -73.4
 Mar. 31 2022  -0.94       -0.92      -1.00     Missed  -8.3​
 Dec. 31 2021  -0.95       -0.83      -1.12     Missed  -34.1
 ​​Sep.        -0.85       -0.87      -0.94     Missed  -8.5
 30 2021                                                
 Jun. 30 2021  -0.92       -0.84      -1.02     Missed  -21.7​
 Mar. 31 2021  -0.85       -0.81      -1.04     Missed  -28.1
 Dec. 31 2020  -0.74       -0.72      -1.05     Missed  -45.4
 This summary was machine generated March 14 at 21:08 GMT.  All
figures in US dollars  unless otherwise stated